Product NDC: | 68220-143 |
Proprietary Name: | Proctofoam |
Non Proprietary Name: | pramoxine hydrochloride |
Active Ingredient(s): | 150 mg/15g & nbsp; pramoxine hydrochloride |
Administration Route(s): | RECTAL |
Dosage Form(s): | AEROSOL, FOAM |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68220-143 |
Labeler Name: | Alaven Pharmaceutical LLC |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part346 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 19900930 |
Package NDC: | 68220-143-15 |
Package Description: | 1 CONTAINER in 1 CARTON (68220-143-15) > 15 g in 1 CONTAINER |
NDC Code | 68220-143-15 |
Proprietary Name | Proctofoam |
Package Description | 1 CONTAINER in 1 CARTON (68220-143-15) > 15 g in 1 CONTAINER |
Product NDC | 68220-143 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | pramoxine hydrochloride |
Dosage Form Name | AEROSOL, FOAM |
Route Name | RECTAL |
Start Marketing Date | 19900930 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | Alaven Pharmaceutical LLC |
Substance Name | PRAMOXINE HYDROCHLORIDE |
Strength Number | 150 |
Strength Unit | mg/15g |
Pharmaceutical Classes |